This week we are looking at the CV system and pharmacology
This week you may again choose your own case from this list:
Don't use plagiarized sources. Get Your Custom Essay on
ph2
Just from $13/Page
Case Study 1:
Patient AO has a history of obesity and has recently gained 9 pounds. The patient has been diagnosed with hypertension and hyperlipidemia. Drugs currently prescribed include the following:
Atenolol 12.5 mg daily
Doxazosin 8 mg daily
Hydralazine 10 mg qid
Sertraline 25 mg daily
Simvastatin 80 mg daily
Case Study 2:
Patient HM has a history of atrial fibrillation and a transient ischemic attack (TIA). The patient has been diagnosed with type 2 diabetes, hypertension, hyperlipidemia and ischemic heart disease. Drugs currently prescribed include the following:
Warfarin 5 mg daily MWF and 2.5 mg daily T, TH, Sat, Sun
Aspirin 81 mg daily
Metformin 1000 mg po bid
Glyburide 10 mg bid
Atenolol 100 mg po daily
Motrin 200 mg 1–3 tablets every 6 hours as needed for pain
Case Study 3:
Patient CB has a history of strokes. The patient has been diagnosed with type 2 diabetes, hypertension, and hyperlipidemia. Drugs currently prescribed include the following:
Glipizide 10 mg po daily
HCTZ 25 mg daily
Atenolol 25 mg po daily
Hydralazine 25 mg qid
Simvastatin 80 mg daily
Verapamil 180 mg CD daily Reference: ACC/ACHA
Guideline on the Management of Blood Cholesterol
http://www.onlinejacc.org/content/accj/73/24/e285.full ?_ga=2.211926493.853299748.1583090983-768093126.1583090983
Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
http://www.onlinejacc.org/content/accj/71/19/e127.full ?_ga=2.119020992.853299748.1583090983-768093126.1583090983
Guideline on the Primary Prevention of Cardiovascular Disease
http://www.onlinejacc.org/content/accj/74/10/e177.full ?_ga=2.120069185.853299748.1583090983-768093126.1583090983
Guideline for the Management of Patients With Atrial Fibrillation
http://www.onlinejacc.org/content/accj/74/1/104.full ?_ga=2.181500014.853299748.1583090983-768093126.1583090983
Guideline for the Management of Heart Failure
http://www.onlinejacc.org/content/accj/70/6/776.full ?_ga=2.182392302.853299748.1583090983-768093126.1583090983
Strategies to Enhance Application of Clinical Practice Guidelines in Patients With Cardiovascular Disease and Comorbid Conditions
http://www.onlinejacc.org/content/accj/64/17/1851.full ?_ga=2.174568939.853299748.1583090983-768093126.1583090983
Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women
http://www.onlinejacc.org/content/accj/57/12/1404.full ?_ga=2.214857950.853299748.1583090983-768093126.1583090983
Guideline for the Evaluation and Management of Patients With Syncope
http://www.onlinejacc.org/content/accj/70/5/e39.full ?_ga=2.186086496.853299748.1583090983-768093126.1583090983
To Prepare
· Review the Resources for this module and consider the impact of potential pharmacotherapeutics for cardiovascular disorders introduced in the media piece.
· Review the case study assigned by your Instructor for this Assignment.
· Select one the following factors: genetics, gender, ethnicity, age, or behavior factors.
· Reflect on how the factor you selected might influence the patient’s pharmacokinetic and pharmacodynamic processes.
· Consider how changes in the pharmacokinetic and pharmacodynamic processes might impact the patient’s recommended drug therapy.
· Think about how you might improve the patient’s drug therapy plan based on the pharmacokinetic and pharmacodynamic changes. Reflect on whether you would modify the current drug treatment or provide an alternative treatment option for the patient.
By Day 7 of Week 2
Write a 2- to 3-page paper that addresses the following:
· Explain how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study you were assigned.
· Describe how changes in the processes might impact the patient’s recommended drug therapy. Be specific and provide examples.
· Explain how you might improve the patient’s drug therapy plan and explain why you would make these recommended improvements.
Reminder: The College of Nursing requires that all papers submitted include a title page, introduction, summary, and references. The College of Nursing Writing Template with Instructions provided at the Walden Writing Center offers an example of those required elements (available at https://academicguides.waldenu.edu/writingcenter/templates/general#s-lg-box-20293632). All papers submitted must use this formatting.
|
Explain how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study you were assigned.
|
23 (23%) – 25 (25%)
The response accurately and completely explains in detail how the factor selected might influence the pharmacokinetic and pharmacodynamic processes in the patient.
|
20 (20%) – 22 (22%)
The response provides a basic explanation of how the factor selected might influence the pharmacokinetic and pharmacodynamic processes in the patient.
|
18 (18%) – 19 (19%)
The response inaccurately or vaguely explains how the factor selected might influence the pharmacokinetic and pharmacodynamic processes in the patient.
|
0 (0%) – 17 (17%)
The response inaccurately and vaguely explains how the factor selected might influence the pharmacokinetic and pharmacodynamic processes in the patient, or is missing.
|
|
Describe how changes in the processes might impact the patient’s recommended drug therapy. Be specific and provide examples.
|
27 (27%) – 30 (30%)
The response accurately and completely describes in detail how changes in the processes might impact the patient’s recommended drug therapy.
Accurate, complete, and aligned examples are provided to support the response.
|
24 (24%) – 26 (26%)
The response accurately describes how changes in the processes might impact the patient’s recommended drug therapy.
Accurate examples may be provided to support the response.
|
21 (21%) – 23 (23%)
The response inaccurately or vaguely describes how changes in the processes might impact the patient’s recommended drug therapy.
Inaccurate or vague examples are provided to support the response.
|
0 (0%) – 20 (20%)
The response inaccurately and vaguely describes how changes in the processes might impact the patient’s recommended drug therapy, or is missing.
Inaccurate and vague examples may be provided to support the response, or is missing.
|
|
Explain how you might improve the patient’s drug therapy plan, and explain why you would make these recommended improvements.
|
27 (27%) – 30 (30%)
The response accurately and clearly explains in detail how to improve the patient’s drug therapy plan.
The response includes an accurate and detailed explanation to support the recommended improvements.
|
24 (24%) – 26 (26%)
The response accurately explains how to improve the patient’s drug therapy plan.
The response may include an accurate explanation to support the recommended improvements.
|
21 (21%) – 23 (23%)
The response inaccurately or vaguely explains how to improve the patient’s drug therapy plan.
The response may include an inaccurate, vague, or misaligned explanation to support the recommended improvements.
|
0 (0%) – 20 (20%)
The response inaccurately and vaguely explains how to improve the patient’s drug therapy plan, or is missing.
The response may include an inaccurate and vague explanation to support the recommended improvements, or is missing.
|
|
Written Expression and Formatting – Paragraph Development and Organization:
Paragraphs make clear points that support well developed ideas, flow logically, and demonstrate continuity of ideas. Sentences are carefully focused–neither long and rambling nor short and lacking substance.
|
5 (5%) – 5 (5%)
Paragraphs and sentences follow writing standards for flow, continuity, and clarity.
|
4 (4%) – 4 (4%)
Paragraphs and sentences follow writing standards for flow, continuity, and clarity 80% of the time.
|
3.5 (3.5%) – 3.5 (3.5%)
Paragraphs and sentences follow writing standards for flow, continuity, and clarity 60%–79% of the time.
|
0 (0%) – 3 (3%)
Paragraphs and sentences follow writing standards for flow, continuity, and clarity less than 60% of the time.
|
|
Written Expression and Formatting – English writing standards:
Correct grammar, mechanics, and proper punctuation
|
5 (5%) – 5 (5%)
Uses correct grammar, spelling, and punctuation with no errors
|
4 (4%) – 4 (4%)
Contains a few (1–2) grammar, spelling, and punctuation errors
|
3.5 (3.5%) – 3.5 (3.5%)
Contains several (3–4) grammar, spelling, and punctuation errors
|
0 (0%) – 3 (3%)
Contains many (≥ 5) grammar, spelling, and punctuation errors that interfere with the reader’s understanding
|
|
Written Expression and Formatting – The paper follows correct APA format for title page, headings, font, spacing, margins, indentations, page numbers, running head, parenthetical/in-text citations, and reference list.
|
5 (5%) – 5 (5%)
Uses correct APA format with no errors
|
4 (4%) – 4 (4%)
Contains a few (1–2) APA format errors
|
3.5 (3.5%) – 3.5 (3.5%)
Contains several (3–4) APA format errors
|
0 (0%) – 3 (3%)
Contains many (≥ 5) APA format errors
|
